Riptide BioScience, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Riptide BioScience, Inc.
Quantité totale PI 23
Rang # Quantité totale PI 66 049
Note d'activité PI 1,7/5.0    8
Rang # Activité PI 115 735

Brevets

Marques

12 0
3 0
8 0
0
 
Dernier brevet 2025 - Cd206 targeted peptide conjugate...
Premier brevet 2015 - Peptide-based methods for treati...

Derniers inventions, produits et services

2023 Invention Cd206 targeted peptide conjugates and methods of using the same. CD206 targeted peptide conjugat...
Invention Cd206 targeted peptide conjugates and methods of using the same. CD206 targeted peptide conjugate...
2022 Invention Methods and compositions for treating calcinosis associated conditions. The present disclosure pr...
2021 Invention Peptides having immunomodulatory properties. The present disclosure provides novel peptides that...
Invention Methods for modulating macrophage activity. Methods according to certain embodiments include cont...
2020 Invention Peptides having anti-inflammatory properties. Aspects of the present invention relate to peptide...
Invention Methods for modulating macrophage activity. Aspects of the present disclosure include methods for...
Invention Antimicrobial peptides and methods of using the same. Aspects of the present invention relate to ...
2019 Invention Peptides having immunomodulatory properties. The present disclosure provides novel peptides that ...
2018 Invention Peptides having immunomodulatory properties.
Invention Antimicrobial peptides and methods of use thereof. Aspects of the present invention relate to pe...
2016 Invention Peptides having anti-inflammatory properties. Aspects of the present invention relate to peptides...
Invention Antimicrobial peptides and methods of use thereof. Aspects of the present invention relate to pep...
2015 Invention Peptide-based methods for treating pancreatic cancer. Methods for treating a subject for pancreat...
Invention Peptide-based methods for treating pancreatic cancer. Methods for treating pancreatic cancer via ...